本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Viking Therapeutics, Inc.

32.01
-0.0600-0.19%
盤後32.200.1900+0.59%19:59 EDT
成交量:339.45萬
成交額:1.09億
市值:35.95億
市盈率:-27.76
高:33.16
開:32.16
低:31.28
收:32.07
資料載入中...
2021/04/08

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/02/17

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/17

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/06

重要事件披露

8-K - Current report
2020/10/28

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/28

重要事件披露

8-K - Current report
2020/08/28

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/29

重要事件披露

8-K - Current report
2020/05/21

重要事件披露

8-K - Current report
2020/04/30

重要事件披露

8-K - Current report
2020/04/30

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/03/17

重要事件披露

Current report, item 7.01
2020/02/26

員工持股計劃

Securities to be offered to employees in employee benefit plans
2020/02/26

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals